ABSTRACT. A total of 159 Thai isolates of Mycoplasma hyopneumoniae isolated from pneumonic lungs of pigs during 2006-2011 were investigated for their in vitro susceptibility to 12 antimicrobial agents. Low activity of chlortetracycline was indicated by the MIC range from 3.12-100 μg/ml and MIC 90 of 50 μg/ml. Seventy-six isolates showed resistance to enrofloxacin, whereas 2 isolates showed resistance to macrolides and lincomycin. In addition, a point mutation at A2058G was revealed by sequence analysis of 23S ribosomal RNA in both isolates. The present results confirmed the rapid increase of resistant M. hyopneumoniae isolates against chlortetracycline, enrofloxacin, macrolides and lincomycin in Thailand. Selection of drugs to control swine diseases in Thailand must be done more prudently in consideration of reducing the antimicrobial resistance. Mycoplasma hyopneumoniae is recognized as one of the most important pathogens in pigs. Management practices, medication and vaccination are control measures of the disease [12] . In Thailand, antimicrobials are generally given to piglets to control diarrhea and respiratory problems during weaning to fattening as well as to gilt and sow during gilt acclimatization and lactation [15] . Excessive medication may cause a decrease of susceptibility of mycoplasmas against antimicrobial agents [11, 21, 23] . To date, antimicrobial resistance of porcine mycoplasmas has been reported to tetracyclines, macrolides, lincomycin and flumequine, the first generation fluoroquinolone in some countries [1, 6, 17, 21, 22] . In Thailand, susceptibility of M. hyopneumoniae to antimicrobial agents was investigated for the isolates collected in 1997-1998, and no resistant isolates were found in that period [14] . In this study, susceptibilities of recent field isolates of M. hyopneumoniae collected during 2006-2011 were examined. M. hyopneumoniae field isolates showing resistance to macrolides and lincomycin were examined for 23S rRNA transition as an evidence of in vivo acquired resistance of M. hyopnuemoniae to macrolides and lincomycin in Thailand.
Mycoplasma hyopneumoniae is recognized as one of the most important pathogens in pigs. Management practices, medication and vaccination are control measures of the disease [12] . In Thailand, antimicrobials are generally given to piglets to control diarrhea and respiratory problems during weaning to fattening as well as to gilt and sow during gilt acclimatization and lactation [15] . Excessive medication may cause a decrease of susceptibility of mycoplasmas against antimicrobial agents [11, 21, 23] . To date, antimicrobial resistance of porcine mycoplasmas has been reported to tetracyclines, macrolides, lincomycin and flumequine, the first generation fluoroquinolone in some countries [1, 6, 17, 21, 22] . In Thailand, susceptibility of M. hyopneumoniae to antimicrobial agents was investigated for the isolates collected in 1997-1998, and no resistant isolates were found in that period [14] . In this study, susceptibilities of recent field isolates of M. hyopneumoniae collected during 2006-2011 were examined. M. hyopneumoniae field isolates showing resistance to macrolides and lincomycin were examined for 23S rRNA transition as an evidence of in vivo acquired resistance of M. hyopnuemoniae to macrolides and lincomycin in Thailand.
One hundred and fifty-nine Thai isolates of M. hyopneumoniae and the type strain J obtained from National Institute of Animal Health (NIAH), Japan were used. Of the Thai isolates, 7 were isolated from pneumonic lungs of pigs from 5 farms in 2006, and 20, 39, 76, 14 and 3 isolates were isolated from 10, 11, 13, 6 and 1 farms in 2007, 2008, 2009, 2010 and 2011, respectively. The lung samples collected from pneumonic lesions of pigs, either by the farmers whose pigs were clinically affected with respiratory problems or by the veterinarians at the slaughter house to monitor the respiratory diseases in the farms, were submitted to NIAH, Thailand for identification of the causative agents. Focusing on M. hyopneumoniae infection, the primary isolation was carried out in BHL broth and BHL agar medium as described previously [23] . Cultures identified as M. hyopneumoniae by colony characterization and by specific PCR [13] were stocked at −80°C until use.
The following 12 antimicrobial agents generally applied in pig industry in Thailand were used; Chlortetracycline (CTC) [ Minimal inhibitory concentration (MIC) test was carried out by broth microdilution method with some modifications [5, 16] using flat bottomed microplates with 96 wells. Tests were read after incubation of 7 days at 37°C, and the lowest concentration of a drug inhibiting any detectable color change of the medium was regarded as MIC of the drug.
PCR amplification and sequencing of domain V of 23S rRNA of M. hyopneumoniae were performed as follows. One milliliter of well grown M. hyopneumoniae isolates showing high MICs level of macrolides and lincomycin was centrifuged at 12,000 × g for 10 min (model 1920, Kubota, Tokyo, Japan). After washing the pellet with 1 ml *CorrespondenCe to: thongkamkoon, P., National Institute of Animal Health, Kaset Klang, Chatuchak, Bangkok 10900, Thailand. e-mail: thongkamkoon@msn.com ©2013 The Japanese Society of Veterinary Science PBS, the pellet was mixed with Instagene matrix (Biorad, Hercules, CA, U.S.A.) to prepare the DNA template for PCR according to the manufacturer's instructions. The specific primer sequences for amplification of domain V of 23S rRNA of M. hyopneumoniae were as follows: Mhp Dom5F 5'-AAGCGGAGATGTTAGCCTA-3' and Mhp DomR 5'-TCTCCCACCTATCCTACACA-3', amplification size of 277 bp [10] . Amplification was performed in a total volume of 50 µl containing Go taq green (Promega, Medison, WI, U.S.A.), 25 µl; 0.8 µM of each primer; 4 µl of DNA template and DW up to 50 µl. The PCR assay was carried out in a Thermal cycler (Hybaid, Thermo electron, Needham, MA, U.S.A.), comprising pre-incubation at 94°C for 2 min, followed by 30 cycles of 30 sec at 94°C, 30 sec at 60°C and 30 sec at 68°C. Final extension was performed for 5 min at 68°C. The amplicons, purified by 2% agarose gel electrophoresis, were sequenced with ABI 3130 Genetic Analyzer (Applied Biosystems, Foster City, CA, U.S.A.), according to the manufacturer's instructions.
The distribution of the MICs obtained for 159 Thai isolates tested is shown in Table 1 . MIC for type strain J as well as the MIC breakpoint values of the 12 tested antimicrobials is also presented in Table 1 . Tiamulin (TM) showed the lowest MICs of 0.013 or lower to 0.2 μg/ml against 158 of 159 isolates (MIC 90 =0.1 μg/ml). Next to TM, tylosin (TS) and lincomycin (LCM) showed high activity with MIC 90 of 0.39 μg/ml, however, two isolates were resistant to these drugs showing a MIC value of higher than 12.5 μg/ml. Of the two isolates, one was isolated from an affected pig in a farm in 2007, and the other was isolated from a healthy pig in another farm in 2010. However, two isolates obtained from different pigs in the latter farm were sensitive to lincomycin and macrolides. Three macrolides, spiramycin (SPM), josamycin (JM) and kitasamycin (KT), also showed high potency with MIC 90 of 0.78, 0.78 and 1.56 μg/ml, respectively. Of the five macrolides tested, erythromycin (EM) showed exceptionally low activity with MIC 90 of 200 μg/ml. Florfenicol (FFC) showed moderately high activity with MIC range from 0.2 to 6.25 μg/ml and MIC 90 of 1.56 μg/ml. Oxytetracycline (OTC) and doxycycline (DOXY) showed similar activity with FFC, and their MIC range was distributed from 0.39 to 12.5 μg/ml with MIC 90 of 6.25 μg/ ml. On the other hand, activity of chlortetracycline (CTC) to Thai isolates of M. hyopneumoniae was low with MIC range from 3.12 to 100 μg/ml and MIC 90 of 50 μg/ml. MIC values of enrofloxacin (ERFX) were distributed in a broad range from 0.1 to 25 μg/ml and MICs for 76 of 159 (47.7%) Thai isolates, including 13 from affected pigs, exceeded 2 μg/ml which is the breakpoint of this drug. Table 2 shows the comparison of susceptibilities of the present 159 isolates with those of isolates isolated from 1997 to 1998 in Thailand [14] . The previous data in CTC, OTC, JM, TS, LCM and TM were tested against 27 Thai isolates of M. hyopneumoniae. Decreases of susceptibilities of the present isolates to some of the drugs were noted. The MIC 90 values of CTC, OTC, JM and TS for previous isolates were 6.25, 0.78, 0.2 and 0.1, and those for present isolates were 50, 6.25, 0.78 and 0.39 μg/ml, respectively. No change was observed in MIC 90 of LCM and TM between the present isolates and the previous ones.
The sequences of domain V of 23 rRNA of the two macrolides and lincomycin resistant isolates were compared with those of M. hyopneumoniae J strain and ATCC 27719 strain (Genbank accession number AE017243 and X68421, respectively). The result revealed a point mutation at A2058G (E.coli coordinates) in both isolates. The MIC values of the antimicrobials for these isolates are shown (underlined) in Table 1 .
It was noteworthy that MICs of ERFX were distributed in a broad range from 0.1 to 25 μg/ml and MICs for 76 of 159 (47.7%) Thai isolates exceeded 2 μg/ml which is considered the breakpoint of this drug [2] . The ERFX resistant animal mycoplasmas have rarely been reported. Hannan et al. [7] reported that some isolates of animal pathogenic mycoplasmas including M. hyosynoviae and M. hyorhinis were resistant to flumequine (breakpoint: >16 μg/ml), the first-generation flu- oroquinolone which has been removed from clinical use and is no longer being marketed, while all of these flumequine resistant isolates were sensitive to ERFX. Vicca et al. [21] described that five of 21 field isolates of M. hyopneumoniae were resistant to flumequine (MIC: >16 μg/ml) and had lower susceptibility to ERFX (MIC: 4 isolates; 0.5 μg/ml, one isolate; >1 μg/ml) than the other isolates (MIC: =0.06 μg/ml).
In all five isolates with lower susceptibility to ERFX, one point mutation in quinolone resistant-determining regions of parC of topoisomerase IV was found, and in one isolate with MIC value of >1 μg/ml, an extra mutation of gyrA was also found. Thai isolates tested here showed higher resistance to ERFX with MIC values of 3.2-25 μg/ml, and in addition, the rate of ERFX resistant isolates was also higher than those reported in the previous papers. This may reflect the overuse of ERFX in pig farming in Thailand, especially for treatment of diarrhea of lactating piglets and at nursery up to 9 weeks [15] . Since the mechanisms of resistance to ERFX of Thai isolates were not examined in the present study, a further study is needed to elucidate whether the resistance to ERFX of Thai isolates comes from alteration of the genes coding for DNA gyrase or reduction of quinolone accumulation by active efflux [8] .
The MICs of chlortetracycline (CTC) for isolates isolated from 2006 to 2011 were higher than those for isolates collected during 1997 to 1998 (MIC90: 50 vs 6.25 μg/ml). Similar results were obtained by previous workers [23] . Most of the Japanese isolates isolated in 1970 were susceptible to CTC at 5 μg/ml or less, while isolates isolated from 1979 to 1981 were clearly separated into two categories (bimodal frequency distribution), one of which was susceptible at 5 μg/ml or less and the other was 20 μg/ml or more [23] . In Thailand, tiamulin (TM), tylosin (TS), CTC and amoxicillin have been widely used in fattening pigs, pregnant and lactating sows and replacement gilts during acclimatization. In this respect, increase of CTC resistant isolates of M. hyopneumoniae is considered reasonable, however, these CTC resistant isolates were still susceptible to oxytetracycline (OTC) and doxycycline (DOXY), though MICs were higher for isolates isolated from 2006 to 2011 than for those from 1997 to 1998 [14] .
Lincomycin and all macrolide drugs except erythromycin (EM) showed a bimodal distribution of MICs. MICs of these drugs were clearly higher for two isolates, indicating acquired resistance. In one farm from which one of the two macrolide resistant strains was derived, additional two strains were isolated and examined for their susceptibility. As a result, these two strains were susceptible to all macrolide drugs tested except erythromycin, indicating that M. hyopneumoniae strains with different antimicrobial susceptibility coexist among pigs within the same farm. The resistance of two strains to macrolides and lincomycin was shown to be attributable to a transition of A to G at 2058 (E. coli coordinates) in the central loop of domain V of the 23S rRNA. It was in agreement to the occurrence in Japan and Belgium [10, 17] . Erythromycin is highly active to M. pneumoniae [9] and M. gallisepticum [4] , however, M. hyopneumoniae has natural resistance to this drug, as indicated not only by the present data but also by the previous reports [18] [19] [20] 23] . This natural resistance of M. hyopneumoniae to EM may be due to a G to A transition at 2057 (E. coli coordinates) in domain V of the 23S rRNA, as suggested by Furneri et al. [3] .
Tiamulin (TM) had the highest activity among 12 antimicrobials tested with the MIC 90 of 0.1 μg/ml, and MICs for 158 of 159 strains were lower or equal to 0.2 μg/ml. The MIC for the remaining isolate was 0.78 μg/ml. Although this value was far lower than the breakpoint of this drug, the strain might be the intermediate stage to resistance. Hence, monitoring of antimicrobial susceptibility at regular interval is inevitable.
In conclusion, this study provided the susceptibilities of Thai isolates of M. hyopneumoniae to 12 antimicrobials using in Thailand. Resistances against CTC, LCM and macrolides were detected. In addition, ERFX resistance in Thai isolates of M. hyopneumoniae was markedly high. Hence, mechanisms of resistance should be elucidated. Acquired resistance to various antimicrobials might pose a serious problem for the treatment of mycoplasma pneumonia of swine. Prudent use of antimicrobials is an urgent necessity in pig industry in Thailand.
